FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/10/059186 [Registered on: 27/10/2023] Trial Registered Prospectively
Last Modified On: 26/10/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Drug 
Study Design  Randomized, Parallel Group, Active Controlled Trial 
Public Title of Study   Comparison of effectiveness of two different doses of nebulised dexmedetomidine with lignocaine for awake fibreoptic intubation. 
Scientific Title of Study   "Comparison of effectiveness of two different doses of nebulized dexmedetomidine with lignocaine for awake fibreoptic intubation in patients under general anaesthesia: A randomized double-blinded controlled study" 
Trial Acronym  nil 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Surendra Kumar Sethi  
Designation  Associate Professor 
Affiliation  Ravindra nath Tagore medical college udaipur Rajasthan 
Address  Department of Anaesthesiology Ravindra nath Tagore medical college udaipur Rajasthan
PINCODE -313001
Udaipur
RAJASTHAN
313001
India 
Phone  9587150598  
Fax  9587150598  
Email  drsurendrasethi80@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Surendra Kumar Sethi  
Designation  ASSOCIATE PROFESSOR 
Affiliation  R.N.T MEDICAL COLLEGE UDAIPUR  
Address  DEPARTMENT OF ANAESTHESIOLOGY R.N.T MEDICAL COLLEGE UDAIPUR
PINCODE -313001
Udaipur
RAJASTHAN
313001
India 
Phone  9587150598  
Fax  9587150598  
Email  drsurendrasethi80@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Dr Abhay kumar lodhi 
Designation  Pg resident 
Affiliation  R.N.T medical college  
Address  Department of anaesthesiology Ravindra nath Tagore medical college udaipur Rajasthan

Udaipur
RAJASTHAN
313001
India 
Phone  7772832656  
Fax    
Email  abhaykumarlodhi@gmail.com  
 
Source of Monetary or Material Support  
Dept of Anaesthesiology, Rabindranath Tagore Medical college Udaipur Rajasthan 313001 
 
Primary Sponsor  
Name  Rabindranath Tagore Medical College 
Address  Dept of Anaesthesiology Rabindranath Tagore Medical College, Udaipur Rajasthan 313001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr abhay kumar lodhi  Maharana Bhupal Government Hospital Udaipur Rajasthan 313001  MAIN SURGERY OT 2 nd floor ,ENT OT,NEURO SURGERY OT 5th floor SSB BUILING,UROLOGY OT 5th floor SSB BUILDING,R.N.T MEDICAL COLLEGE UDAIPUR RAJSTHAN.
Udaipur
RAJASTHAN 
7772832656

abhaykumarlodhi@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
RNT MEDICAL COLLEGE CONTROLLER ATTACHED HOSPITALS UDAIPUR  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: O||Medical and Surgical, (2) ICD-10 Condition: H720||Central perforation of tympanic membrane, (3) ICD-10 Condition: C502||Malignant neoplasm of upper-innerquadrant of breast, (4) ICD-10 Condition: C73||Malignant neoplasm of thyroid gland, (5) ICD-10 Condition: C01||Malignant neoplasm of base of tongue, (6) ICD-10 Condition: C040||Malignant neoplasm of anterior floor of mouth, (7) ICD-10 Condition: H701||Chronic mastoiditis, (8) ICD-10 Condition: H712||Cholesteatoma of mastoid, (9) ICD-10 Condition: K800||Calculus of gallbladder with acutecholecystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  lignocaine 4% 4 ml with dexmedetomidine 2 microgram/kg  In third group we will nebulised patients with ignocaine 4% 4 ml with dexmedetomidine 2 microgram/kg [total 5 ml] before awake fibre optic intubation for 15 minutes. 
Comparator Agent  lignocaine 4% 5ml   Nebulisation with 4%lignocaine 5 ml just before awake fibre optic intubation for 15 minutes. 
Comparator Agent  lignocaine 4% with dexmedetomidine [5ml]  In 2 nd group we will nebulised patients with lignocaine 4% 4ml with dexmedetomidine 1 microgram/kg[total 5 ml] before awake fibre optic intubation for 15 minutes. 
Intervention  AWAKE FIBER OPTIC INTUBATION  Comparison of effectiveness of two different doses of nebulised dexmedetomidine with lignocaine for awake fibreoptic intubation in patients undergoing surgery under general anaesthesia.In first group we will give lignocaine plan & and in 2 nd & 3rd group we will give 1&2 microgram dexmedetomidine with 4% lignocaine respectively in each group. 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  2.Patients with American Society of Anesthesiologists (ASA) Physical Status (PS) I and II
3.Patients with Mallampati Class I and II 
 
ExclusionCriteria 
Details  1. Patients who have not given consent.
2.Patients with age <18 and >50 years
3. Patients with ASA PS III and IV and Mallampati class III and IV
4. Patients with BMI >35 kg/m2 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Participant and Investigator Blinded 
Primary Outcome  
Outcome  TimePoints 
Cough severity score during awake fiber optic intubation  During awake fiber optic intubation (2 minutes) 
 
Secondary Outcome  
Outcome  TimePoints 
Intubation comfort score
Post intubation behavior score/Assessment
Post operative patient satisfaction score
Ramsay sedation score
Haemodynamics
Side effects like nausea/vomiting ,bradycardia,hypotension,respiratory depression ,oxygen desaturation etc. 
Upto 24 hr post operatively 
 
Target Sample Size   Total Sample Size="96"
Sample Size from India="96" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 4 
Date of First Enrollment (India)   06/11/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="15" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Among the various methods to facilitate AFOI, topical anaesthesia with LA (lignocaine) nebulisation is a commonly used technique. However, topical anaesthesia with lignocaine alone may be inadequate in some patients.
 Dexmedetomidine, a selective alpha- 2 adrenergic agonist, that provides both analgesia and sedation without causing respiratory depression.    Only two studies have been done where this combination (dexmedetomidine in a dose of 0.6 µg/kg  and 1 µg/kg)   has been   used for flexible fiberoptic bronchoscopy Till date.We hypothesised that combination of nebulised dexmedetomidine-lidocaine could reduce the incidence of moderate to severe coughing during AFOI
 With more intubation comfort, better post-intubation tolerance and patient satisfaction along with adequate sedation and stable haemodynamics.The present study has been planned with an aim of comparing the effectiveness of two different doses of nebulised dexmedetomidine with lignocaine for AFOI in patients undergoing surgery under general anaesthesia.

 
Close